Raymond James Financial
BMY icon

Raymond James Financial’s Bristol-Myers Squibb BMY Stock Holding History

Raymond James Financial’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$105K Hold
2,000
– – ﹤0.01% 5027
2025
Q4 		$96K Buy
+2,000
New +$96.2K ﹤0.01% 4932

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial's BMY Position: Q1 2026 in Review

Raymond James Financial reduced its Bristol-Myers Squibb (BMY) stake by 1.4% in Q1 2026, selling an estimated $3.31M and leaving 3,921,135 shares worth $238M. The position accounts for 0.07% of the portfolio, ranked #239.

Raymond James Financial first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $337M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Raymond James Financial held 3,921,135 shares of Bristol-Myers Squibb worth $238M as of Q1 2026.
  • Raymond James Financial sold 56,734 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.31M.
  • Bristol-Myers Squibb made up 0.07% of Raymond James Financial's portfolio in Q1 2026, its #239 holding.
  • Raymond James Financial first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Bristol-Myers Squibb position peaked at $337M in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.